(NUVL) Nuvalent - Performance -7.7% in 12m
Compare NUVL with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
61.64%
#11 in Group
Rel. Strength
40.30%
#4625 in Universe
Total Return 12m
-7.68%
#49 in Group
Total Return 5y
264.37%
#13 in Group
P/E -
(unknown) Percentile in Group
P/E Forward -
(unknown) Percentile in Group
PEG -
(unknown) Percentile in Group
FCF Yield -3.75%
(unknown) Percentile in Group
12m Total Return: NUVL (-7.7%) vs XBI (-14%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-4.65% | 17.9% | 229% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
-0.86% | 32.9% | 221% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-1.23% | 27.5% | 43.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-0.3% | 16.4% | 70.8% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
LONN SW Lonza |
-7.03% | -0.49% | 38.3% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.85% | 21.5% | 13.9% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
-4.86% | 15.4% | 6.78% | 27 | 25 | 1 | 58.7% | 15% |
ERF PA Eurofins Scientific SE |
0.82% | -17.5% | 16.4% | 23.9 | 12.7 | 0.58 | -70.8% | -17.1% |
Performance Comparison: NUVL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for NUVL
Total Return (including Dividends) | NUVL | XBI | S&P 500 |
---|---|---|---|
1 Month | -3.82% | -8.71% | -7.79% |
3 Months | -15.42% | -15.44% | -9.06% |
12 Months | -7.68% | -14.04% | 4.64% |
5 Years | 264.37% | -2.41% | 117.94% |
Trend Score (consistency of price movement) | NUVL | XBI | S&P 500 |
1 Month | -9.20% | -62.6% | -5.5% |
3 Months | -56.4% | -73% | -61.9% |
12 Months | 36.1% | -8.4% | 82.8% |
5 Years | 88.9% | -50% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #51 | 5.36% | 4.31% |
3 Month | #54 | 0.01% | -7.0% |
12 Month | #49 | 7.41% | -11.8% |
5 Years | #6 | 483% | 184% |
FAQs
Does NUVL Nuvalent outperforms the market?
Yes,
over the last 12 months NUVL made -7.68%, while its related Sector, the SPDR S&P Biotech (XBI) made -14.04%.
Over the last 3 months NUVL made -15.42%, while XBI made -15.44%.
Over the last 3 months NUVL made -15.42%, while XBI made -15.44%.
Performance Comparison NUVL vs Indeces and Sectors
NUVL vs. Indices NUVL is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -1.84% | 3.97% | -29.1% | -12.3% |
US NASDAQ 100 | QQQ | -0.77% | 5.38% | -27.9% | -10.2% |
US Dow Jones Industrial 30 | DIA | -3.01% | 2.22% | -31.2% | -12.9% |
German DAX 40 | DAX | -2.96% | 2.50% | -48.0% | -25.2% |
Shanghai Shenzhen CSI 300 | CSI 300 | -4.56% | -3.02% | -18.9% | -15.8% |
Hongkong Hang Seng | HSI | -5.35% | -4.80% | -25.6% | -24.2% |
India NIFTY 50 | INDA | -6.02% | -10.9% | -23.9% | -7.43% |
Brasil Bovespa | EWZ | -7.20% | -12.9% | -28.3% | 3.64% |
NUVL vs. Sectors NUVL is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -1.0% | 4.28% | -37.5% | -20.7% |
Consumer Discretionary | XLY | -1.14% | 5.81% | -32.1% | -14.8% |
Consumer Staples | XLP | -8.70% | -2.54% | -36.3% | -20.6% |
Energy | XLE | -0.60% | -3.36% | -29.5% | 0.05% |
Financial | XLF | -2.24% | 3.67% | -41.1% | -24.0% |
Health Care | XLV | -5.93% | 0.12% | -29.3% | -8.66% |
Industrial | XLI | -1.90% | 2.25% | -28.3% | -9.82% |
Materials | XLB | -3.09% | 0.21% | -22.6% | 1.14% |
Real Estate | XLRE | -5.73% | 1.78% | -28.8% | -17.6% |
Technology | XLK | 0.50% | 6.74% | -21.9% | -2.47% |
Utilities | XLU | -9.15% | -4.01% | -32.4% | -32.6% |
Aerospace & Defense | XAR | -2.22% | -0.43% | -34.1% | -22.9% |
Biotech | XBI | 1.44% | 4.89% | -14.9% | 6.36% |
Homebuilder | XHB | -0.15% | 3.12% | -9.03% | 7.17% |
Retail | XRT | -0.79% | 4.71% | -22.4% | 3.89% |